Bares Capital Management Has Increased By $661,971 Its Costar Group (CSGP) Holding; Altimmune (ALT) Shorts Raised By 54.04%

December 6, 2017 - By Kurt Siggers

Altimmune Incorporated (NASDAQ:ALT) had an increase of 54.04% in short interest. ALT’s SI was 535,900 shares in December as released by FINRA. Its up 54.04% from 347,900 shares previously. With 100,300 avg volume, 5 days are for Altimmune Incorporated (NASDAQ:ALT)’s short sellers to cover ALT’s short positions. The stock decreased 3.24% or $0.06 during the last trading session, reaching $1.79. About 148,284 shares traded or 33.15% up from the average. Altimmune, Inc. (NASDAQ:ALT) has 0.00% since December 6, 2016 and is . It has underperformed by 16.70% the S&P500.

Bares Capital Management Inc increased Costar Group (CSGP) stake by 0.46% reported in 2017Q2 SEC filing. Bares Capital Management Inc acquired 2,517 shares as Costar Group (CSGP)’s stock rose 21.01%. The Bares Capital Management Inc holds 553,711 shares with $145.96M value, up from 551,194 last quarter. Costar Group now has $10.62B valuation. The stock increased 0.43% or $1.25 during the last trading session, reaching $293.84. About 174,966 shares traded. CoStar Group, Inc. (NASDAQ:CSGP) has risen 29.48% since December 6, 2016 and is uptrending. It has outperformed by 12.78% the S&P500.

Altimmune, Inc., a clinical stage immunotherapeutic biotechnology company, creates and develops immunotherapeutic products for treating acute respiratory infections, chronic viral infections, and cancer. The company has market cap of $27.97 million. The firm develops NasoVAX, an intranasally administered recombinant influenza vaccine that has completed Phase I clinical trials; and HepTcell, an immunotherapy for patients chronically infected with the hepatitis B virus, which is in Phase I clinical trials. It currently has negative earnings. The Company’s preclinical stage products include NasoShield, a vaccine for the prevention of anthrax disease following inhalation of pathogen spores; and Oncosyn, an immunotherapeutic for treating solid cancer indications, such as lung, colorectal, melanoma, breast, ovarian, and others.

Among 8 analysts covering CoStar Group (NASDAQ:CSGP), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CoStar Group had 15 analyst reports since August 12, 2015 according to SRatingsIntel. The stock has “Buy” rating by SunTrust on Friday, October 20. The company was initiated on Tuesday, December 20 by Citigroup. Needham initiated CoStar Group, Inc. (NASDAQ:CSGP) on Monday, August 22 with “Buy” rating. The firm earned “Buy” rating on Thursday, October 26 by SunTrust. The rating was maintained by Bank of America with “Buy” on Thursday, October 5. The stock has “Hold” rating by Zacks on Wednesday, August 12. The stock has “Buy” rating by Needham on Thursday, October 26.

Investors sentiment increased to 1.1 in Q2 2017. Its up 0.19, from 0.91 in 2017Q1. It improved, as 21 investors sold CSGP shares while 96 reduced holdings. 47 funds opened positions while 82 raised stakes. 30.60 million shares or 0.65% less from 30.80 million shares in 2017Q1 were reported. Ahl Ptnrs Limited Liability Partnership reported 0.04% in CoStar Group, Inc. (NASDAQ:CSGP). Neuberger Berman Grp Ltd Liability Corporation invested in 141,272 shares or 0.05% of the stock. Brown Advisory holds 0.03% of its portfolio in CoStar Group, Inc. (NASDAQ:CSGP) for 39,459 shares. Elk Creek Prtnrs Limited Liability Corp stated it has 20,374 shares or 0.35% of all its holdings. Schwab Charles Investment Mngmt Inc has 0.02% invested in CoStar Group, Inc. (NASDAQ:CSGP). Aperio Gp Limited Liability invested in 7,489 shares or 0.01% of the stock. First Quadrant Lp Ca owns 300 shares or 0% of their US portfolio. Kbc Group Nv reported 4,528 shares or 0.01% of all its holdings. Waddell & Reed Fincl invested in 0.36% or 625,850 shares. Cibc Asset holds 1,040 shares. Pnc Serv Grp Inc Inc has invested 0.01% in CoStar Group, Inc. (NASDAQ:CSGP). Trust Co Of Vermont invested in 0% or 18 shares. World Asset Management has invested 0.01% in CoStar Group, Inc. (NASDAQ:CSGP). L S Advsr reported 2,405 shares or 0.11% of all its holdings. Stephens Investment Management Ltd Liability Company reported 1.75% in CoStar Group, Inc. (NASDAQ:CSGP).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :